Literature DB >> 7494886

Androgen and progestagen effects on plasma lipids.

C J Bagatell1, W J Bremner.   

Abstract

Androgens are 19-carbon steroid rings. Progestagens include both 19-carbon and 21-carbon steroid rings; the 19-carbon progestagens are generally more androgenic than are the 21-carbon compounds. Both androgens and progestagens are physiological regulators of plasma lipids, particularly high-density lipoprotein (HDL) cholesterol. The structure of a particular hormonal preparation, as well as its route of administration, modulates its regulatory effects. Both endogenous and exogenous androgens have a suppressive effect on HDL cholesterol in males, with little effect on other plasma lipoproteins. Oral and nonaromatizable androgens have a greater suppressive effect on HDL cholesterol, particularly on HDL2, than do aromatizable androgens. Cross-sectional studies in males generally show a positive relationship between serum T and plasma HDL levels; data in females suggest an inverse relationship between androgens and HDL cholesterol. Medroxy-progesterone acetate and related progestagens have a mild suppressive effect on plasma HDL levels. The C-19 compounds have a greater suppressive effect on HDL cholesterol and the HDL2 density subfraction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494886     DOI: 10.1016/s0033-0620(95)80016-6

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  7 in total

Review 1.  Risks versus benefits of testosterone therapy in elderly men.

Authors:  S Basaria; A S Dobs
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

Review 2.  Androgen replacement therapy: present and future.

Authors:  Louis J G Gooren; Mathijs C M Bunck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Androgen deficiency in the aging male: pathophysiology, diagnosis, and treatment alternatives.

Authors:  V Flynn; W J Hellstrom
Journal:  Curr Urol Rep       Date:  2001-12       Impact factor: 2.862

Review 4.  Pharmacology of testosterone replacement therapy preparations.

Authors:  Jennifer J Shoskes; Meghan K Wilson; Michael L Spinner
Journal:  Transl Androl Urol       Date:  2016-12

5.  Endogenous Estradiol and Testosterone may Predispose toward Atherogenic Lipid Profile, but Higher Blood Level of Testosterone is Associated with Lower Number of Stenoses in the Coronary Arteries of Men with Coronary Disease.

Authors:  Jerzy Krzysztof Wranicz; Iwona Cygankiewicz; Piotr Kula; Renata Walczak-Jedrzejowska; Jolanta Slowikowska-Hilczer; Krzysztof Kula
Journal:  Int J Biomed Sci       Date:  2006-06

Review 6.  Testosterone depot injection in male hypogonadism: a critical appraisal.

Authors:  Aksam A Yassin; Mohamed Haffejee
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

7.  Estradiol Does Not Influence Lipid Measures and Inflammatory Markers in Testosterone-Clamped Healthy Men.

Authors:  Ferdinand Roelfsema; Rebecca J Yang; Johannes D Veldhuis
Journal:  J Endocr Soc       Date:  2018-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.